JHS Svendgaard Laboratories Ltd

AGM Details

• Date: 26 September 2026; mode: VC/OAVM; time not disclosed.

Key Resolutions

• Adopt standalone audited financial statements for the year ended 31 March 2026 and auditors' report.
• Adopt consolidated audited financial statements for the year ended 31 March 2026 and auditors' report.
• Appoint Paramvir Singh as director, liable to retire by rotation.

Voting Results

• Standalone statements: passed with 99.9999% in favour; negligible dissent.
• Consolidated statements: passed with 99.9979% in favour; minimal dissent.
• Director appointment: passed with 99.9979% in favour; minimal dissent.

AGM details

• Date and time: 26 September 2026, 03:00 PM IST.
• Mode: VC/OAVM.
• Quorum: 88 members present.
• Conducted as per MCA/SEBI guidelines via VC/OAVM.

Ordinary business resolutions

• Item 1: Adopt standalone financial statements for the year ended 31 March 2026.
• Item 2: Adopt consolidated financial statements for the year ended 31 March 2026.
• Item 3: Appoint Paramvir Singh as director, liable to retire by rotation.

Voting and disclosures

• Voting results to be published on company and NSDL portals and filed with exchanges.
• Auditors' reports for 2025-26 had no qualifications.

JHS Svendgaard Laboratories Ltd — Trading Window closed from October 1, 2026 till 48 hours after the declaration of Un-audited Financial Results for the Quarter and Half Year ended September 30, 2026

AGM notice and annual report access

• Dispatch of letter to shareholders with web-link and QR code for Annual Report 2025-26 and AGM notice.
• 22nd AGM scheduled for September 26, 2026, at 3:00 PM IST via VC/OAVM.
• E-voting starts Sept 23, 2026 at 9:00 AM; ends Sept 25, 2026 at 5:00 PM IST.
• E-voting entitlement cut-off date: Sept 19, 2026.
• Annual Report and AGM notice accessible on BSE and NSE websites.

KYC and transfer regulatory updates

• KYC updation reminder per SEBI circular; required fields include PAN, address, mobile, bank details, nomination; email optional.
• SEBI relodgement window for physical transfers: 7 Jul 2025–6 Jan 2026; second window 5 Feb 2026–4 Feb 2027.
• RTA processing of complete cases per SEBI guidelines.

agm details

• AGM on 26 September 2026 at 3:00 PM IST via VC/OAVM.
• Mode confirmed as VC/OAVM under MCA circulars.
• Cut-off date for e-voting: 19 September 2026.
• Remote e-voting window: 23–25 September 2026.
• Notice approved by Board on 11 August 2026.
• Scrutinizer for e-voting appointed: Dahiya & Associates.
• Attendance dispensed; proxies not allowed due to VC/OAVM.

ordinary resolutions

• Adopt Audited Standalone Financial Statements for FY 2025-26.
• Adopt Audited Consolidated Financial Statements for FY 2025-26.
• Re-appoint Paramvir Singh as Director, liable to retirement by rotation.

director/remuneration

• Paramvir Singh to be reappointed as Executive Director; retirement by rotation.
• Remuneration and committee roles disclosed in annexure.

annexure/notice details

• Annexure provides details required under Regulation 30 for director retiring by rotation.
• Annexure outlines director’s general background and board committee memberships.

Financial highlights

• Revenue from operations ₹10169.47 lakhs; up 10.5% YoY.
• Total income ₹10514.34 lakhs; up 10.8% YoY.
• PBT ₹-228.54 lakhs; PAT ₹-191.73 lakhs; losses narrowed.
• EPS (basic) ₹-0.22; EPS (diluted) ₹-0.22.
• Dividend declared for FY2025-26: none.
• Cash flow from operations ₹-202.83 lakhs; net cash usage ₹299.12 lakhs.
• Product mix: Toothbrush 62%; Toothpaste 24%; Talcum 11%; Others 3%.
• Geography: India ₹9,865.45 lakhs; Italy ₹237.14; USA ₹53.53; Nepal ₹13.35.
• ESOPs: 33.8 million options granted; 0 vested as of 31 Mar 2026.
• Warrants: 18,01,801 converted; 18,01,801 lapsed; equity capital ₹87.4057 crore.

Business model & progress

• Integrated contract manufacturer in FMCG, private-label focus.
• Kala Amb, HP facility; 235+ employees; strong R&D centre.
• Strengthened core business; expanded product portfolio and exports.
• Onboarded Denver product range; expanded private-label partnerships.
• MD: Nikhil Nanda; CEO: Paramvir Singh; 2 Execs; 3 Independent Dirs.
• ISO 9001:2015, ISO 13485, GMP, US FDA registrations; AYUSH license.
• Management focus on automation, regulatory compliance, and product innovation.

Geography and product mix

• India revenue ~₹9,865.5 lakhs; Nepal ₹13.3; Italy ₹237.1; USA ₹53.5.
• Toothbrush remains dominant at 62% of turnover.
• Toothpaste 24%; Talcum 11%; Others 3%.
• Export markets growing; European regulatory compliance pursued.

Capital structure & liquidity

• Paid-up equity capital ₹87.4057 crore; 8,740,57,670 shares.
• Previous year ₹85.60 crore; warrants converted; 18,01,801 warrants lapsed.
• ESOP 2025: up to 40,00,000 options; 33,80,000 granted; ₹10 exercise price.
• Total borrowings ₹1,481.24 lakhs; cash ₹373.67; bank balances ₹1,534.54.
• Promoter holding 30.31% as on 31 Mar 2026.

Governance & risk

• Board of 6 directors: 2 exec, 1 non-exec non-independent, 3 independent (1 woman).
• Ten Board meetings in FY2025-26; independent director familiarisation conducted.
• Audit Committee: 4 directors; majority independent; 7 meetings held.
• NRC: 3 independent; 6 meetings; CSR committee in place.
• Statutory auditors VK Khosla & Co; unqualified report; no fraud reported.

Related-party transactions & CSR

• Material related-party transactions disclosed; arm's-length policy followed.
• Investments: JHS Retail Ventures Limited ₹112.50; Sixth Sense India Opportunities ₹297.36.
• JHS Svendgaard Retail Ventures Limited loan; corporate guarantee ₹500 lakh to SIDBI.
• Paramvir Singh ESOP grants; related-party sales/purchases within ordinary course.

Outlook and risks

• Focus on core FMCG manufacturing, product diversification, and export expansion.
• Risks: foreign exchange, raw material costs, regulatory changes, competition.
• Outlook for 2026-27 remains positive with ongoing capex and automation.
• Internal controls reviewed; plan to strengthen critical areas from internal audit findings.

Shareholder info & AGM

• AGM 22nd scheduled for 26 Sep 2026 via VC/OAVM.
• E-voting window Sep 23-25, 2026; cutoff Sep 19, 2026.
• Dividend nil; Beetal as RTA; annual report on company website.

Deviation status and utilisation

• Mode of fund raising: Preferential Issue.
• Date of raising funds: 04 June 2024.
• Amount raised: Rs. 29.99 crores.
• Deviation/variation: No.
• Monitoring agency: Not applicable.
• Quarter for report: Quarter ended June 30, 2026.
• Status of fund utilisation: No deviation; utilisation figures disclosed.